The Flavonoid Kaempferol Mitigates Periprosthetic Osteolysis by Regulating the NLRP3 Inflammasome and Balancing Bone Metabolism
Journal of Cellular and Molecular Medicine · 2025
DOI: 10.1111/jcmm.70878 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Cheng Huang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopeadics, China-Japan Friendship Hospital, Beijing, China. Hauptthemen laut MEDLINE: NLR Family, Pyrin Domain-Containing 3 Protein, Osteolysis, Inflammasomes, Kaempferols. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gusu Health Talents Program, Suzhou Science and Technology Development Plan, Natural Science Foundation of Jiangsu Province.
Abstract (Originalsprache)
Total joint arthroplasty (TJA) is an effective intervention for end‐stage arthritis; however, its long‐term success is often compromised by wear particle–induced osteolysis, leading to aseptic loosening and implant failure. This study investigates the potential of kaempferol (Ka), a natural flavonoid with anti‐inflammatory properties, to alleviate osteolysis by modulating NLRP3 inflammasome activation. In a murine calvarial osteolysis model, Ka administration significantly attenuated bone loss induced by CoCrMo alloy particles. Mechanistically, Ka dose‐dependently inhibited NLRP3 inflammasome activation in macrophages, as evidenced by reduced IL‐1β secretion, decreased ASC oligomerisation and suppressed GSDMD cleavage, ultimately leading to decreased pyroptosis. These effects were found to be partially mediated via GPR109a. Furthermore, Ka markedly suppressed osteoclast differentiation and activity both in vivo and in vitro while promoting osteoblast differentiation, thereby contributing to the restoration of bone remodelling balance. Taken together, our findings suggest that Ka exerts a protective effect against wear particle–induced osteolysis by targeting the NLRP3 inflammasome and modulating osteoimmune responses, which may offer a novel therapeutic strategy to manage periprosthetic osteolysis and prolong implant longevity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopeadics, China-Japan Friendship Hospital, Beijing, China.
- Department of Orthopaedics, The Fourth Affiliated Hospital of Soochow University, SuzhouDushu Lake Hospital, Medical Center of Soochow University, Suzhou, China.
- Department of Orthopaedics, The Second Affiliated Hospital of XuZhou Medical University, Xuzhou, China.
- Department of Orthopaedics, The First Affiliated Hospital of Soochow University, Soochow University, Suzhou, China.
- Department of Spinal Surgery, School of Medicine, Shanghai East Hospital, Tongji University, Shanghai, China.
ORCID-Profile: Junjie Niu
Förderung
- Gusu Health Talents Program
- Suzhou Science and Technology Development Plan
- Natural Science Foundation of Jiangsu Province
- Elite Medical Professionals Project of China-Japan Friendship Hospital
- Technology Innovation on Medicine and Health of Suzhou Science and Technology Bureau
- National Natural Science Foundation of China
- National High Level Hospital Clinical Research Funding
- National Youth Talent Support Program
Zitieren
APA
Huang, C., Zhang, C., Luo, Y., Guo, L., Wu, Y., Shi, Q., Zhang, Y., Yang, C., Wang, B., Niu, J., & Lin, J. (2025). The Flavonoid Kaempferol Mitigates Periprosthetic Osteolysis by Regulating the NLRP3 Inflammasome and Balancing Bone Metabolism. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70878
Vancouver
Huang C, Zhang C, Luo Y, Guo L, Wu Y, Shi Q, et al. The Flavonoid Kaempferol Mitigates Periprosthetic Osteolysis by Regulating the NLRP3 Inflammasome and Balancing Bone Metabolism. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70878
BibTeX
@article{Huang2025,
author = {Huang, Cheng and Zhang, Chenhui and Luo, Yongjun and Guo, Lujun and Wu, Yanglin and Shi, Qingyan and Zhang, Yazhong and Yang, Chengyuan and Wang, Bo and Niu, Junjie and Lin, Jun},
title = {The Flavonoid Kaempferol Mitigates Periprosthetic Osteolysis by Regulating the NLRP3 Inflammasome and Balancing Bone Metabolism},
journal = {Journal of Cellular and Molecular Medicine},
year = {2025},
doi = {10.1111/jcmm.70878}
}
EUVIMED